News Roche keeps Rituxan evergreen with Breakthrough designation,... Roche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Ri
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
